These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 28187777)

  • 1. GMP-conformant on-site manufacturing of a CD133
    Skorska A; Müller P; Gaebel R; Große J; Lemcke H; Lux CA; Bastian M; Hausburg F; Zarniko N; Bubritzki S; Ruch U; Tiedemann G; David R; Steinhoff G
    Stem Cell Res Ther; 2017 Feb; 8(1):33. PubMed ID: 28187777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenic Potential of Bone Marrow Derived CD133
    Sasse S; Skorska A; Lux CA; Steinhoff G; David R; Gaebel R
    Cells; 2019 Dec; 9(1):. PubMed ID: 31892273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automation of cellular therapy product manufacturing: results of a split validation comparing CD34 selection of peripheral blood stem cell apheresis product with a semi-manual vs. an automatic procedure.
    Hümmer C; Poppe C; Bunos M; Stock B; Wingenfeld E; Huppert V; Stuth J; Reck K; Essl M; Seifried E; Bonig H
    J Transl Med; 2016 Mar; 14():76. PubMed ID: 26983643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated CD34+ cell isolation of peripheral blood stem cell apheresis product.
    Spohn G; Wiercinska E; Karpova D; Bunos M; Hümmer C; Wingenfeld E; Sorg N; Poppe C; Huppert V; Stuth J; Reck K; Essl M; Seifried E; Bönig H
    Cytotherapy; 2015 Oct; 17(10):1465-71. PubMed ID: 25981397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramyocardial fate and effect of iron nanoparticles co-injected with MACS
    Müller P; Gaebel R; Lemcke H; Wiekhorst F; Hausburg F; Lang C; Zarniko N; Westphal B; Steinhoff G; David R
    Biomaterials; 2017 Aug; 135():74-84. PubMed ID: 28494265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Full GMP-compliant validation of bone marrow-derived human CD133(+) cells as advanced therapy medicinal product for refractory ischemic cardiomyopathy.
    Belotti D; Gaipa G; Bassetti B; Cabiati B; Spaltro G; Biagi E; Parma M; Biondi A; Cavallotti L; Gambini E; Pompilio G
    Biomed Res Int; 2015; 2015():473159. PubMed ID: 26495296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyzing migratory properties of human CD133(+) stem cells in vivo after intraoperative sternal bone marrow isolation.
    Donndorf P; Useini D; Lux CA; Vollmar B; Delyagina E; Laupheimer M; Kaminski A; Steinhoff G
    Cell Transplant; 2013; 22(9):1627-35. PubMed ID: 23051098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic stem-cell senescence and myocardial repair - Coronary artery disease genotype/phenotype analysis of post-MI myocardial regeneration response induced by CABG/CD133+ bone marrow hematopoietic stem cell treatment in RCT PERFECT Phase 3.
    Wolfien M; Klatt D; Salybekov AA; Ii M; Komatsu-Horii M; Gaebel R; Philippou-Massier J; Schrinner E; Akimaru H; Akimaru E; David R; Garbade J; Gummert J; Haverich A; Hennig H; Iwasaki H; Kaminski A; Kawamoto A; Klopsch C; Kowallick JT; Krebs S; Nesteruk J; Reichenspurner H; Ritter C; Stamm C; Tani-Yokoyama A; Blum H; Wolkenhauer O; Schambach A; Asahara T; Steinhoff G
    EBioMedicine; 2020 Jul; 57():102862. PubMed ID: 32629392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical isolation and functional characterization of cord blood CD133+ hematopoietic progenitor cells.
    Bonanno G; Perillo A; Rutella S; De Ritis DG; Mariotti A; Marone M; Meoni F; Scambia G; Leone G; Mancuso S; Pierelli L
    Transfusion; 2004 Jul; 44(7):1087-97. PubMed ID: 15225252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both CD133(+) cells and monocytes provide significant improvement for hindlimb ischemia, although they do not transdifferentiate into endothelial cells.
    Sanchez-Guijo FM; Oterino E; Barbado MV; Carrancio S; Lopez-Holgado N; Muntion S; Hernandez-Campo P; Sanchez-Abarca LI; Perez-Simon JA; San Miguel JF; Briñon JG; del Cañizo MC
    Cell Transplant; 2010; 19(1):103-12. PubMed ID: 19818207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133
    Bassetti B; Carbucicchio C; Catto V; Gambini E; Rurali E; Bestetti A; Gaipa G; Belotti D; Celeste F; Parma M; Righetti S; Biava L; Arosio M; Bonomi A; Agostoni P; Scacciatella P; Achilli F; Pompilio G
    Stem Cell Res Ther; 2018 Sep; 9(1):235. PubMed ID: 30217223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferation and differentiation potential of CD133+ and CD34+ populations from the bone marrow and mobilized peripheral blood.
    Koutna I; Peterkova M; Simara P; Stejskal S; Tesarova L; Kozubek M
    Ann Hematol; 2011 Feb; 90(2):127-37. PubMed ID: 20821012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramyocardial delivery of human CD133+ cells in a SCID mouse cryoinjury model: Bone marrow vs. cord blood-derived cells.
    Ma N; Ladilov Y; Moebius JM; Ong L; Piechaczek C; Dávid A; Kaminski A; Choi YH; Li W; Egger D; Stamm C; Steinhoff G
    Cardiovasc Res; 2006 Jul; 71(1):158-69. PubMed ID: 16730684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large-scale isolation of CD133+ progenitor cells from G-CSF mobilized peripheral blood stem cells.
    Gordon PR; Leimig T; Babarin-Dorner A; Houston J; Holladay M; Mueller I; Geiger T; Handgretinger R
    Bone Marrow Transplant; 2003 Jan; 31(1):17-22. PubMed ID: 12621502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery.
    Klein HM; Ghodsizad A; Marktanner R; Poll L; Voelkel T; Mohammad Hasani MR; Piechaczek C; Feifel N; Stockschlaeder M; Burchardt ER; Kar BJ; Gregoric I; Gams E
    Heart Surg Forum; 2007; 10(1):E66-9. PubMed ID: 17162408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium.
    Agbulut O; Vandervelde S; Al Attar N; Larghero J; Ghostine S; Léobon B; Robidel E; Borsani P; Le Lorc'h M; Bissery A; Chomienne C; Bruneval P; Marolleau JP; Vilquin JT; Hagège A; Samuel JL; Menasché P
    J Am Coll Cardiol; 2004 Jul; 44(2):458-63. PubMed ID: 15261948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GMP-based CD133(+) cells isolation maintains progenitor angiogenic properties and enhances standardization in cardiovascular cell therapy.
    Gaipa G; Tilenni M; Straino S; Burba I; Zaccagnini G; Belotti D; Biagi E; Valentini M; Perseghin P; Parma M; Campli CD; Biondi A; Capogrossi MC; Pompilio G; Pesce M
    J Cell Mol Med; 2010 Jun; 14(6B):1619-34. PubMed ID: 19627397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of serum-free ex vivo-expanded hematopoietic stem cells derived from human umbilical cord blood CD133(+) cells.
    Yao CL; Feng YH; Lin XZ; Chu IM; Hsieh TB; Hwang SM
    Stem Cells Dev; 2006 Feb; 15(1):70-8. PubMed ID: 16522164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac Function Improvement and Bone Marrow Response -: Outcome Analysis of the Randomized PERFECT Phase III Clinical Trial of Intramyocardial CD133
    Steinhoff G; Nesteruk J; Wolfien M; Kundt G; ; Börgermann J; David R; Garbade J; Große J; Haverich A; Hennig H; Kaminski A; Lotz J; Mohr FW; Müller P; Oostendorp R; Ruch U; Sarikouch S; Skorska A; Stamm C; Tiedemann G; Wagner FM; Wolkenhauer O
    EBioMedicine; 2017 Aug; 22():208-224. PubMed ID: 28781130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and isolation from either adult human bone marrow or G-CSF-mobilized peripheral blood of CD34(+)/CD133(+)/CXCR4(+)/ Lin(-)CD45(-) cells, featuring morphological, molecular, and phenotypic characteristics of very small embryonic-like (VSEL) stem cells.
    Sovalat H; Scrofani M; Eidenschenk A; Pasquet S; Rimelen V; Hénon P
    Exp Hematol; 2011 Apr; 39(4):495-505. PubMed ID: 21238532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.